Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - POWDER;INTRAVENOUS - 175MG/VIAL
USFDA APPLICATION NUMBER - 211226
DOSAGE - POWDER;INTRAVENOUS - 300MG/VIAL
USFDA APPLICATION NUMBER - 211226
Related Excipient Companies
Digital Content
NEWS #PharmaBuzz
Global Sales Information
ABOUT THIS PAGE
27
PharmaCompass offers a list of Levoleucovorin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Levoleucovorin manufacturer or Levoleucovorin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levoleucovorin manufacturer or Levoleucovorin supplier.
PharmaCompass also assists you with knowing the Levoleucovorin API Price utilized in the formulation of products. Levoleucovorin API Price is not always fixed or binding as the Levoleucovorin Price is obtained through a variety of data sources. The Levoleucovorin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Levoleucovorin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levoleucovorin, including repackagers and relabelers. The FDA regulates Levoleucovorin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levoleucovorin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levoleucovorin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levoleucovorin supplier is an individual or a company that provides Levoleucovorin active pharmaceutical ingredient (API) or Levoleucovorin finished formulations upon request. The Levoleucovorin suppliers may include Levoleucovorin API manufacturers, exporters, distributors and traders.
click here to find a list of Levoleucovorin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Levoleucovorin DMF (Drug Master File) is a document detailing the whole manufacturing process of Levoleucovorin active pharmaceutical ingredient (API) in detail. Different forms of Levoleucovorin DMFs exist exist since differing nations have different regulations, such as Levoleucovorin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Levoleucovorin DMF submitted to regulatory agencies in the US is known as a USDMF. Levoleucovorin USDMF includes data on Levoleucovorin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Levoleucovorin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Levoleucovorin suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levoleucovorin Drug Master File in Korea (Levoleucovorin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levoleucovorin. The MFDS reviews the Levoleucovorin KDMF as part of the drug registration process and uses the information provided in the Levoleucovorin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levoleucovorin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levoleucovorin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levoleucovorin suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levoleucovorin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levoleucovorin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levoleucovorin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levoleucovorin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levoleucovorin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levoleucovorin suppliers with NDC on PharmaCompass.
Levoleucovorin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levoleucovorin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levoleucovorin GMP manufacturer or Levoleucovorin GMP API supplier for your needs.
A Levoleucovorin CoA (Certificate of Analysis) is a formal document that attests to Levoleucovorin's compliance with Levoleucovorin specifications and serves as a tool for batch-level quality control.
Levoleucovorin CoA mostly includes findings from lab analyses of a specific batch. For each Levoleucovorin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levoleucovorin may be tested according to a variety of international standards, such as European Pharmacopoeia (Levoleucovorin EP), Levoleucovorin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levoleucovorin USP).
